Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Leica Microsystems and Bausch + Lomb Sign Global Agreement

Published: Friday, April 19, 2013
Last Updated: Friday, April 19, 2013
Bookmark and Share
Bausch + Lomb to distribute Leica Microsystems’ medical products to ophthalmic customers in select global markets.

Leica Microsystems and Bausch + Lomb have announced that Bausch + Lomb will distribute Leica ophthalmic surgical microscopes, and accessories in select markets across Europe, the United States, India and Latin America beginning this month.

The partnership combines the strength of Leica Microsystems’ innovative ophthalmic microscopes with Bausch + Lomb’s global commercial infrastructure, while expanding Bausch + Lomb’s offerings for ophthalmic surgeons.

Bausch + Lomb’s current portfolio of products for cataract, refractive and retinal surgery includes intraocular lenses, equipment, instruments, procedure packs, and other supplies.

With the recent purchase of Technolas™ Perfect Vision GmbH, an ophthalmology laser company based in Munich, Germany, the company has become an emerging leader in femto second laser technology for cataract surgery.

Under this agreement, Bausch + Lomb can now offer Leica Microsystems’ ophthalmic portfolio, which ranges from routine cataract microscopes to high-end retinal systems.

Among these is the Leica M822 for cataract procedures which combines LED and halogen lighting for a stable red reflex.

John Barr, executive vice president and president, Bausch + Lomb Global Surgical, commented, “We are happy to announce the partnership of two leading companies in the field of eye surgery. Bausch + Lomb is a perfect partner for companies, such as Leica Microsystems, looking to broaden their market reach through a powerful worldwide commercial infrastructure. Leica Microsystems is a trusted, established brand in the industry and the company is known for their innovative microscopes and scientific instruments. We are excited to offer Leica surgical microscopes, as they enhance our ability to offer a ‘one-stop shop’ for an ophthalmic surgeons’ needs, while also accelerating the growth of our business.”

“Through this partnership with Bausch + Lomb, we will be able to provide more patients around the world with better access to our world-leading imaging systems," added Eoghan O'Lionaird, president, Leica Microsystems.

O'Lionaird continued, “We are pleased to have such a respected and innovative company as Bausch + Lomb as our partner. Our customers, their patients, and our business will benefit from this collaboration as ophthalmic surgeons will have a single source supplier for their equipment needs.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Yale University and Leica Microsystems Partner
Yale welcomes scientists to participate in core facility opening and super-resolution workshops October 20 through 31, 2014.
Tuesday, September 30, 2014
Leica Microsystems and Leica Biosystems Strengthen Market Position in Brazil
Long-standing Leica distributors Aotec have been acquired.
Tuesday, April 23, 2013
R&D 100 Award for Super-Resolution Microscope from Leica Microsystems
Leica SR GSD convinces jury with unprecedented performance in fluorescence microscopy.
Monday, August 06, 2012
Leica Microsystems Acquires Labindia’s Microscopy and Histopathology Divisions
High-tech market leader is set to boost growth with a local presence in India.
Thursday, November 17, 2011
License Agreement Between Leica Microsystems, the Max Planck Society and DKFZ
Developing the next Stimulated Emission Depletion microscopy generation.
Monday, November 14, 2011
Leica Announces new Chief Financial Officer
Martin Geisel has been announced as new CFO.
Monday, October 02, 2006
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!